ALK-positive large B-cell lymphomas: A clinicopathologic study

ALK-positive large B-cell lymphomas: A clinicopathologic study

Background and Aim: Anaplastic lymphoma kinase (ALK)-positive large B-cell lymphomas (ALK+-LBCLs) are aggressive CD20-negative lymphomas, accounting for <1% of diffuse LBCLs. Being rare and with peculiar immunophenotypic characteristics, these can be easily misdiagnosed. We present 11 cases of AL...

Full description

Bibliographic Details
Main Authors: Jagan Chandramohan, Gautami Ganapule, Elanthenral Sigamani, Biju George, Anu Korula, Marie T Manipadam
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
aggressive b-cell non-hodgkin lymphoma
anaplastic lymphoma kinase
cd20-negative large b-cell lymphoma
large cell lymphoma with plasmablastic differentiation
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2022;volume=65;issue=2;spage=381;epage=386;aulast=Chandramohan

Internet

http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2022;volume=65;issue=2;spage=381;epage=386;aulast=Chandramohan

Similar Items